The current landscape of treatment for HR-MDS: an update from ASH 2023

The current landscape of treatment for HR-MDS: an update from ASH 2023

Current and future treatment approaches for HR-MDSПодробнее

Current and future treatment approaches for HR-MDS

Current landscape and future directions for lower-risk MDS treatmentПодробнее

Current landscape and future directions for lower-risk MDS treatment

Advancing the treatment of MDS and AML: An update from ASH 2021Подробнее

Advancing the treatment of MDS and AML: An update from ASH 2021

MDS - Myeloplastic Syndromes - 2023 Best of Hematology ConferenceПодробнее

MDS - Myeloplastic Syndromes - 2023 Best of Hematology Conference

Promising treatment options emerging for higher-risk MDS & the value of clinical trialsПодробнее

Promising treatment options emerging for higher-risk MDS & the value of clinical trials

Current landscape of treatment for SCD: an update from ASH 2023Подробнее

Current landscape of treatment for SCD: an update from ASH 2023

Introduction: Treatment Landscape of MDSПодробнее

Introduction: Treatment Landscape of MDS

The current landscape of immunotherapy for AML: an update from ASH 2023Подробнее

The current landscape of immunotherapy for AML: an update from ASH 2023

State-of-the-art treatment for HR-MDSПодробнее

State-of-the-art treatment for HR-MDS

Exciting updates in higher-risk MDS at ASH 2022Подробнее

Exciting updates in higher-risk MDS at ASH 2022

Current and emerging treatment options for MDSПодробнее

Current and emerging treatment options for MDS

Latest updates in the treatment of LR-MDS: COMMANDS and IMerge trialsПодробнее

Latest updates in the treatment of LR-MDS: COMMANDS and IMerge trials

An overview of the current and future treatment landscape for MPNsПодробнее

An overview of the current and future treatment landscape for MPNs

Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and managementПодробнее

Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management

The current landscape of maintenace therapy in AML and areas for future explorationПодробнее

The current landscape of maintenace therapy in AML and areas for future exploration

The current state of the art in HR-MDS and the need to improve treatment approachesПодробнее

The current state of the art in HR-MDS and the need to improve treatment approaches

Updates from ASH 2020: Promising Treatment Advances for MDS and AMLПодробнее

Updates from ASH 2020: Promising Treatment Advances for MDS and AML